Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis

MLA

Kristof Vansteelandt, et al. “Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.” CNS Drugs, vol. 33, May 2019, pp. 549–66. EBSCOhost, https://doi.org/10.1007/s40263-019-00625-3.

APA

Kristof Vansteelandt, Koen Demyttenaere, Johan Detraux, & Giorgio Racagni. (2019). Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis. CNS Drugs, 33, 549–566. https://doi.org/10.1007/s40263-019-00625-3

Chicago

Kristof Vansteelandt, Koen Demyttenaere, Johan Detraux, and Giorgio Racagni. 2019. “Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.” CNS Drugs 33 (May): 549–66. doi:10.1007/s40263-019-00625-3.